Loading...
Skip to Content

Bibliografia Tecnologia coniugata

Purification of capsular polysaccharides from contaminant LPS

The biological and physico- chemical characteristics of meningococcus polysaccharide Group C prepared by two different methods of purification

Porro M. & al.
J. Biol. Standard., 8: 7-13 1980.

Vaccines based on the mutant diphteria protein CRM197

Immunogenic correlation between cross-reacting material (CRM197) produced by a mutant of C. diphtheriae and diphtheria toxoid

Porro M. & al.
J. Infect. Dis. 142: 716 724 1980.

Determination of group-specific polysaccharides in multivalent vaccines

Immunoelectrophoretic characterization of the molecular weight polydispersion of polysaccharides in multivalent bacterial capsular polysaccharide vaccines

Porro M. & al.
J. Biol. Stand., 11:65-74 1983.

Development of glycoconjugate vaccines combining the first generation of reductive animation with ester-activated linkers

Immunochemistry of Meningococcal group B oligosaccharide-protein conjugates

Porro M. & al.
Medicine Tropicale, 43:129-132 1983.

Development of glycoconjugate vaccines combining the first generation of reductive animation with ester-activated linkers

Specific antibodies to diphteria toxin and type 6A Pneumococcal capsular polysaccharide induced by a model of semi-synthetic glycoconjugate antigen

Porro M. & al.
Medicine Tropicale, 43:129-132 1985.

Development of glycoconjugate vaccines combining the first generation of reductive animation with ester-activated linkers

A semi-synthetic glycoconjugate antigen prepared by chemical glycosylation of pertussis toxin by a meningococcal group C oligosaccharide hapten

Porro M. & al.
Develop. Biol. Standard., Karger S. Ed. Basel, Vol 61, pp 525-530 1985.

Development of glycoconjugate vaccines with built-in multiple specificities

A molecular model of artificial gycoprotein with predetermined multiple immunodeterminants for Gram-Positive and Gram-negative encapsulated bacteria

Porro M. & al.
Molec. Immunol., 23 (4):385-391 1986

Development of glycoconjugate vaccines with built-in multiple specificities

Artificial glycoproteins of predetermined multivalent antigenicity as a new generation of candidate vaccines to prevent infections from encapsulated bacteria

Porro M.
Towards better carbohydrate vaccines Edited by R.Bell and G. Torrigiani, World Health Organization pp 279-306, John Wiley & Sons Publishers 1987

Development of glycoconjugate vaccines combining the second generation of reductive amination with ester-activated

Strategies for type-specific glycoconjugate vaccines of Streptococcus pneumoniae

Arndt B., Porro M.
Immunobiology of proteins and peptides, vol.VI. Edited by M.Z. Atassi, Plenum Press, New York, p. 129-148 1991.

La nostra tecnologia si basa su 30 anni di esperienza

Developed by